These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23023937)

  • 101. Genomic Characterization of a Rare, de Novo Unbalanced ins(3;1)(p25.3;q21.3q23.3) in a Female Child with Multiple Congenital Anomalies.
    Ornelas-Arana ML; Pérez-Garcia G; Robles-Espinoza CD; Rangel-Sosa MM; Castaneda-Garcia C; Juárez-Vázquez CI; López-Pérez LG; Pérez-Ornelas C; Hernández-Zaragoza G; Lara-Aguilar RA; Córdova-Fletes C
    Cytogenet Genome Res; 2020; 160(10):579-588. PubMed ID: 33152732
    [TBL] [Abstract][Full Text] [Related]  

  • 102. 10q26.1 Microdeletion: Redefining the critical regions for microcephaly and genital anomalies.
    Choucair N; Abou Ghoch J; Fawaz A; Mégarbané A; Chouery E
    Am J Med Genet A; 2015 Nov; 167A(11):2707-13. PubMed ID: 26114870
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Microdeletion of the Down syndrome critical region at 21q22.
    Fujita H; Torii C; Kosaki R; Yamaguchi S; Kudoh J; Hayashi K; Takahashi T; Kosaki K
    Am J Med Genet A; 2010 Apr; 152A(4):950-3. PubMed ID: 20358607
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A 6.5 mb deletion at 3q24q25.2 narrows Wisconsin syndrome critical region to a 750 kb interval: A potential role for MBNLI.
    Bertini V; Orsini A; Mazza R; Mandava V; Saggese G; Azzara' A; Bonuccelli A; Valetto A
    Am J Med Genet A; 2017 Jan; 173(1):280-284. PubMed ID: 27753286
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Interstitial deletion of 2q24.2: further delineation of an emerging syndrome associated with intellectual disability, severe hypotonia and moderate intrauterine growth restriction.
    Yokoyama E; Villarroel CE; Del Castillo V; Torres L; Sánchez S; Molina B; Avila S; Castrillo JL; Navarrete-Meneses P; Frías S
    Am J Med Genet A; 2014 Mar; 164A(3):824-7. PubMed ID: 24357343
    [No Abstract]   [Full Text] [Related]  

  • 106. An interstitial duplication at 2q24.3 involving the SCN1A, SCN2A, SCN3A genes associated with infantile epilepsy.
    Raymond G; Wohler E; Dinsmore C; Cox J; Johnston M; Batista D; Wang T
    Am J Med Genet A; 2011 Apr; 155A(4):920-3. PubMed ID: 21416599
    [No Abstract]   [Full Text] [Related]  

  • 107. Scoliosis and vertebral anomalies: additional abnormal phenotypes associated with chromosome 16p11.2 rearrangement.
    Al-Kateb H; Khanna G; Filges I; Hauser N; Grange DK; Shen J; Smyser CD; Kulkarni S; Shinawi M
    Am J Med Genet A; 2014 May; 164A(5):1118-26. PubMed ID: 24458548
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Microdeletion 5q14.3 and anomalies of brain development.
    Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ
    Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Long-term course of early onset developmental and epileptic encephalopathy associated with 2q24.3 microduplication.
    Masuda T; Osaka H; Tsuchida N; Miyatake S; Nishimura K; Takenouchi T; Takahashi T; Matsumoto N; Yamagata T
    Epilepsy Behav Rep; 2022; 19():100547. PubMed ID: 35733834
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Craniosynostosis in 10q26 deletion patients: A consequence of brain underdevelopment or altered suture biology?
    Faria ÁC; Rabbi-Bortolini E; Rebouças MRGO; de S Thiago Pereira ALA; Frasson MGT; Atique R; Lourenço NCV; Rosenberg C; Kobayashi GS; Passos-Bueno MR; Errera FIV
    Am J Med Genet A; 2016 Feb; 170A(2):403-409. PubMed ID: 26566760
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Clinical and molecular characterization of 1q43q44 deletion and corpus callosum malformations: 2 new cases and literature review.
    Khadija B; Rjiba K; Dimassi S; Dahleb W; Kammoun M; Hannechi H; Miladi N; Gouider-Khouja N; Saad A; Mougou-Zerelli S
    Mol Cytogenet; 2022 Oct; 15(1):42. PubMed ID: 36192753
    [TBL] [Abstract][Full Text] [Related]  

  • 112. 5q31.3 Microdeletion syndrome: clinical and molecular characterization of two further cases.
    Brown N; Burgess T; Forbes R; McGillivray G; Kornberg A; Mandelstam S; Stark Z
    Am J Med Genet A; 2013 Oct; 161A(10):2604-8. PubMed ID: 23950017
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Interstitial 11q deletion: genomic characterization and neuropsychiatric follow up from early infancy to adolescence and literature review.
    Nacinovich R; Villa N; Redaelli S; Broggi F; Bomba M; Stoppa P; Scatigno A; Selicorni A; Dalprà L; Neri F
    BMC Res Notes; 2014 Apr; 7():248. PubMed ID: 24742288
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Molecular characterization of an interstitial deletion of 1p31.3 in a patient with obesity and psychiatric illness and a review of the literature.
    Petti M; Samanich J; Pan Q; Huang CK; Reinmund J; Farooqi S; Morrow B; Babcock M
    Am J Med Genet A; 2011 Apr; 155A(4):825-32. PubMed ID: 21416589
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Genotype-Phenotype Correlation of 2q37 Deletions Including NPPC Gene Associated with Skeletal Malformations.
    Tassano E; Buttgereit J; Bader M; Lerone M; Divizia MT; Bocciardi R; Napoli F; Pala G; Sloan-Béna F; Gimelli S; Gimelli G
    PLoS One; 2013; 8(6):e66048. PubMed ID: 23805197
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Interstitial 2q24.2q24.3 Microdeletion: Two New Cases with Similar Clinical Features with the Exception of Profound Deafness.
    Tassano E; Uccella S; Ronchetto P; Martinheira Da Silva JS; Viaggi S; Mancardi M; Ramenghi L; Murri A; Biondi M; Gimelli G; Morerio C; Malacarne M; Coviello D
    Cytogenet Genome Res; 2022; 162(3):132-139. PubMed ID: 35896065
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A tale of two deletions: a report of two novel 20p13 --> pter deletions.
    McGill AK; Pastore MT; Herman GE; Alliman S; Rosenfeld JA; Weaver DD
    Am J Med Genet A; 2010 Apr; 152A(4):1000-7. PubMed ID: 20358616
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2.
    Zarate YA; Bosanko KA; Thomas MA; Miller DT; Cusmano-Ozog K; Martinez-Monseny A; Curry CJ; Graham JM; Velsher L; Bekheirnia MR; Seidel V; Dedousis D; Mitchell AL; DiMarino AM; Riess A; Balasubramanian M; Fish JL; Caffrey AR; Fleischer N; Pierson TM; Lacro RV
    Clin Genet; 2021 Apr; 99(4):547-557. PubMed ID: 33381861
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Microdeletion of 6q16.1 encompassing EPHA7 in a child with mild neurological abnormalities and dysmorphic features: case report.
    Traylor RN; Fan Z; Hudson B; Rosenfeld JA; Shaffer LG; Torchia BS; Ballif BC
    Mol Cytogenet; 2009 Aug; 2():17. PubMed ID: 19664229
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Genotype-Phenotype Correlations for Putative Haploinsufficient Genes in Deletions of 6q26-q27: Report of Eight Patients and Review of Literature.
    Xie X; Chai H; DiAdamo A; Grommisch B; Wen J; Zhang H; Li P
    Glob Med Genet; 2022 Jun; 9(2):166-174. PubMed ID: 35707784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.